Kims Impex Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-07-2024
- Paid Up Capital ₹ 0.10 M
as on 05-07-2024
- Company Age 17 Year, 20 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.58 Cr
as on 05-07-2024
- Revenue 79.69%
(FY 2022)
- Profit 145.24%
(FY 2022)
- Ebitda 25.47%
(FY 2022)
- Net Worth 124.11%
(FY 2022)
- Total Assets 2.26%
(FY 2022)
About Kims Impex
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.58 Cr.
Praveen Mehtani and Tarachand Mehtani serve as directors at the Company.
- CIN/LLPIN
U74900GJ2007PTC052283
- Company No.
052283
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Dec 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Kims Impex Private Limited offer?
Kims Impex Private Limited offers a wide range of products and services, including Candy & Jelly, Mint Candy.
Who are the key members and board of directors at Kims Impex?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praveen Mehtani  | Director | 06-Dec-2007 | Current |
| Tarachand Mehtani | Director | 06-Dec-2007 | Current |
Financial Performance of Kims Impex.
Kims Impex Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 79.69% increase. The company also saw a substantial improvement in profitability, with a 145.24% increase in profit. The company's net worth Soared by an impressive increase of 124.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kims Impex?
In 2022, Kims Impex had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Smooth Ayurvedic Pharmacy Private LimitedActive 21 years 2 monthsPraveen Mehtani and Tarachand Mehtani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 Feb 2021 | ₹2.90 M | Open |
Others Creation Date: 14 Aug 2020 | ₹2.90 M | Open |
Deutsche Bank Ag Creation Date: 31 Aug 2013 | ₹1.00 Cr | Open |
How Many Employees Work at Kims Impex?
Unlock and access historical data on people associated with Kims Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kims Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kims Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
